BioSig Technologies, Inc.

📍 Westport, United States🗓 Founded 2009👥 50 employees💰 Last funded 2021
Medical Device🌐 biosig.com
Website LinkedIn
BioSig Technologies is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. By leveraging a first of its kind combination of hardware and software, we deliver unprecedented cardiac signal clarity, ending the reliance on ‘mixed signals’ and ‘reading between the lines.’ Our platform technology is addressing some of healthcare’s biggest challenges—saving time, saving costs, and saving lives. The PURE EP™ Platform, an FDA 510(k) cleared non-invasive class II device, provides superior, real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures with increased procedural efficiency. An innovation in one of the most critical areas of electrophysiology, PURE EP™ is revitalizing the value of the EGM, preserving elaborate cardiac signals in their original format— pure from beginning to end. Interested in joining our team? Check out our available opportunities by visiting: www.biosig.com/join-our-team.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in BioSig Technologies, Inc.?
BioSig Technologies, Inc. has 1 investors on record on gritt.io.
When did BioSig Technologies, Inc. last raise funding?
The most recent investment in BioSig Technologies, Inc. recorded on gritt.io was in 2021.
When was BioSig Technologies, Inc. founded?
BioSig Technologies, Inc. was founded in 2009.
What industry is BioSig Technologies, Inc. in?
BioSig Technologies, Inc. operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is BioSig Technologies, Inc. based?
BioSig Technologies, Inc. is headquartered in Westport, United States.